Harvey Investment Co Has Cut By $538,625 Its Idexx Laboratories (IDXX) Position; Univar Inc. (UNVR) Covered By 7 Bullish Analysts Last Week

February 22, 2018 - By Linda Rogers

Among 10 analysts covering Univar Inc (NYSE:UNVR), 7 have Buy rating, 1 Sell and 2 Hold. Therefore 70% are positive. Univar Inc had 30 analyst reports since July 28, 2015 according to SRatingsIntel. As per Thursday, August 31, the company rating was maintained by Credit Suisse. Credit Suisse initiated it with “Neutral” rating and $25 target in Thursday, July 30 report. Credit Suisse upgraded the shares of UNVR in report on Friday, December 9 to “Outperform” rating. William Blair initiated the stock with “Market Perform” rating in Tuesday, July 28 report. The stock has “Equal-Weight” rating by Barclays Capital on Friday, June 24. Bank of America maintained Univar Inc. (NYSE:UNVR) rating on Thursday, August 11. Bank of America has “Buy” rating and $22 target. Jefferies maintained it with “Buy” rating and $39.0 target in Friday, September 15 report. Bank of America initiated the shares of UNVR in report on Tuesday, September 8 with “Neutral” rating. The rating was downgraded by Goldman Sachs on Wednesday, January 20 to “Neutral”. The stock has “Market Perform” rating by Wells Fargo on Thursday, July 30. See Univar Inc. (NYSE:UNVR) latest ratings:

13/02/2018 Broker: SunTrust Rating: Buy New Target: $32.0 Upgrade
05/11/2017 Broker: SunTrust Rating: Hold New Target: $32.0 Maintain
17/10/2017 Broker: Jefferies Rating: Buy New Target: $39.0 Maintain
15/09/2017 Broker: Jefferies Rating: Buy New Target: $39.0 Maintain
30/08/2017 Broker: Barclays Capital Rating: Hold New Target: $32.0
31/08/2017 Broker: Credit Suisse Rating: Outperform Old Target: $39 New Target: $36 Maintain

Harvey Investment Co Llc decreased Idexx Laboratories Inc (IDXX) stake by 3.2% reported in 2017Q3 SEC filing. Harvey Investment Co Llc sold 3,475 shares as Idexx Laboratories Inc (IDXX)’s stock rose 13.64%. The Harvey Investment Co Llc holds 104,981 shares with $16.32 million value, down from 108,456 last quarter. Idexx Laboratories Inc now has $16.03 billion valuation. The stock increased 0.43% or $0.78 during the last trading session, reaching $183.94. About 349,715 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since February 22, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

The stock increased 1.05% or $0.29 during the last trading session, reaching $27.78. About 800,852 shares traded. Univar Inc. (NYSE:UNVR) has risen 70.03% since February 22, 2017 and is uptrending. It has outperformed by 53.33% the S&P500.

Univar Inc. distributes commodity and specialty chemical products, and related services worldwide. The company has market cap of $3.92 billion. It offers herbicides, fungicides, insecticides, seed, micronutrients, macronutrients, horticultural products, fertilizers, and feed; storage, packaging, and logistics services for crop protection companies, storing chemicals, feed-grade materials, and seed and equipment parties; and pest control products and equipment. It has a 116.23 P/E ratio. The firm also provides organic, inorganic, and polymer chemistries; enzymes, surfactants, solvents, dispersants, thickeners, bleaching aides, builders, chelants, alkalis, and other chemicals for the manufacturing of cleaning products; resins, pigments, solvents, thickeners, dispersants, and other additives; and epoxy resins, polyurethanes, titanium dioxides, fumed silica, esters, plasticizers, silicones, and specialty amines.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on April, 27. They expect $0.93 earnings per share, up 43.08% or $0.28 from last year’s $0.65 per share. IDXX’s profit will be $81.02 million for 49.45 P/E if the $0.93 EPS becomes a reality. After $0.77 actual earnings per share reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts 20.78% EPS growth.

Since August 28, 2017, it had 2 buys, and 5 insider sales for $22.12 million activity. The insider AYERS JONATHAN W sold 22,000 shares worth $3.91 million. $178,045 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was bought by Kingsley Lawrence D. The insider Claflin Bruce L. bought $179,580. MCKEON BRIAN P sold $1.20 million worth of stock or 6,602 shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>